Development of Liquid and Solid Self-Emulsifying Drug Delivery System of Silymarin
The objective of our investigation was to formulate a self-emulsifying drug delivery system (SEDDS) of Silymarin using minimum surfactant concentration that could include its solubility, stability and also oral bioavailability. Silymarin are widely use drug for the treatment of hepatitis C virus, have poor bioavailability due to their poor water solubility that limits dissolution rate. To overcome this limitation SEDDS were prepared to attempt their release property. The solubility of the drug was determined by various vehicles. Ternary phase diagram was constructed using Cinnamon (oil), Tween 20 (surfactant) and PEG 200 (co-surfactant) and water to identify the efficient Self-emulsifying region. Through pseudo ternary phase diagram investigation, four different formulations were prepared of liquid-solid SEDDS. The stability can be achieved more by developing the solid dosage form by converting the liquid SEDDS to solid SEDDS formulation. The liquid SEDDS was converted into free flowing powder by adsorption of liquid onto solid carriers by using Aerosil 200 that provides a high surface area. The in vitro release of solid SEDDS was 58.16% within 8 h. The optimized formulation (F1) showed higher dissolution release than the commercial product. The in vitro drug release kinetics study of optimized formula was found better Regression coefficient (R2) compare with other formulation. In conclusion the study elucidated that adsorption to solid carrier technique could be useful method to prepare the solid SEDDS from liquid SEDDS, which can improve oral absorption of Silymain.
Keywords: Silymarin, Self emulsifying drug delivery system, Cinnamon oil, Tween 20, PEG 200.
2. Nigade PM, Patil SL, Tiwari SS, Self emulsifying drug delivery system (SEDDS): A review, International Journal of Pharmacy and Biological Sciences, 2012; 2(2):42-52.
3. Ajay K, Surabh S, Ravindra K, Self-emulsifying drug delivery systems (SEDDS): Future aspects’, International Journal of Pharmacy and Pharmaceutical sciences, 2012; 2(4):7-13.
4. Brahmankar DM, Jaiswal SB, First edition, “Absorption of Drugs” Biopharmaceutics and Pharmacokinetics – A treatise, Vallabh Prakashan, Delhi 1995, 5-75.
5. Dixit N, Baboota S, Kohli K, Ahmad S, Ali J, Silymarin: A review of pharmacological aspects and bioavailability enhancement approaches, Indian journal of pharmacology, 2007; 39(4):172.
6. Saifee M, Zarekar S, Rao VU, Zaheer Z, Soni R, Burande S, Formulation and in vitro evaluation of solid-self-emulsifying drug delivery system (SEDDS) of glibenclamide, American Journal of Advanced Drug Delivery, 2013; 1(3):323-340
7. Iosio T, Voinovich D, Perissutti B, Serdoz F, Hasa D, Grabnar I, Dall’Acqua S, Zara GP, Muntoni E, Pinto JF, Oral bioavailability of silymarin phytocomplex formulated as self-emulsifying pellets, Phytomedicine, 2011; 18(6):505-12
8. Indian Pharmacopoeia; Volume: 1; The Indian Pharmacopoeia Commission, Ghaziabad; 2007; 477
9. Indian Pharmacopoeia; Volume: 1; The Indian Pharmacopoeia Commission, Ghaziabad; 2007; 480
10. Amrutkar C, Salunkhe K, Chaudhari S, Study on self nano emulsifying drug delivery system of poorly water soluble drug rosuvastatin calcium, World Journal of Pharmaceutical Research, 2014; 3(4):2137-51
11. Gupta AK, Mishra DK., Mahajan SC, Preparation and in-vitro evaluation of self emulsifying drug delivery system of antihypertensive drug Valsartan, International Journal of Pharmacy and Life Science, 2011; 2(3):633-638
12. Chanale AM, Raskar MA, Tarkase KN, Formulation and Evaluation of Self Emulsifying Drug Delivery System of Ezetimibe, Der Pharmacia Lettre, 2016; 8(11):164-176
13. Kumar MS, Shailaja P, Murthy K, Pradesh A, Improvement of oral bioavailability of nifedipine through self-microemulsifing drug delivery systems, Journal of Global Trends in Pharmaceutical Sciences, 2011; 2( 3):364-388
14. Bhattacharyya A, Bajpai M, Development and evaluation of a self-emulsifying drug delivery system of amphotericin B, Asian Journal of Pharmaceutics (AJP): Free full text articles from Asian J Pharm, 2014; 6(2):124-128.
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution-NonCommercial 3.0 Unported License. that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (SeeÂ The Effect of Open Access).